PLEKHG6
geneOn this page
Also known as FLJ10665MYOGEFARHGEF46
Summary
PLEKHG6 (pleckstrin homology and RhoGEF domain containing G6, HGNC:25562) is a protein-coding gene on chromosome 12p13.31, encoding Pleckstrin homology domain-containing family G member 6 (Q3KR16). Guanine nucleotide exchange factor activating the small GTPase RHOA, which, in turn, induces myosin filament formation.
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Located in cell junction and centrosome.
Source: NCBI Gene 55200 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 196 total
- MANE Select transcript:
NM_001384598
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25562 |
| Approved symbol | PLEKHG6 |
| Name | pleckstrin homology and RhoGEF domain containing G6 |
| Location | 12p13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10665, MYOGEF, ARHGEF46 |
| Ensembl gene | ENSG00000008323 |
| Ensembl biotype | protein_coding |
| OMIM | 611743 |
| Entrez | 55200 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 17 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000011684, ENST00000304581, ENST00000396988, ENST00000449001, ENST00000535616, ENST00000536531, ENST00000538208, ENST00000543000, ENST00000544743, ENST00000684764, ENST00000898443, ENST00000898444, ENST00000898445, ENST00000898446, ENST00000898447, ENST00000898448, ENST00000928829, ENST00000928830, ENST00000965576, ENST00000965577, ENST00000965579
RefSeq mRNA: 10 — MANE Select: NM_001384598
NM_001144856, NM_001144857, NM_001384598, NM_001384599, NM_001384600, NM_001384601, NM_001384602, NM_001384603, NM_001384604, NM_018173
CCDS: CCDS8541, CCDS91644
Canonical transcript exons
ENST00000684764 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000369301 | 6315005 | 6315169 |
| ENSE00000714928 | 6313629 | 6313784 |
| ENSE00000714929 | 6315554 | 6315649 |
| ENSE00000714930 | 6315869 | 6315919 |
| ENSE00000714931 | 6316255 | 6316404 |
| ENSE00000714932 | 6317303 | 6317413 |
| ENSE00000714933 | 6317547 | 6317696 |
| ENSE00000714935 | 6317857 | 6317994 |
| ENSE00000714937 | 6318301 | 6318420 |
| ENSE00000714938 | 6318745 | 6318877 |
| ENSE00000714940 | 6326428 | 6326573 |
| ENSE00001166966 | 6327254 | 6327946 |
| ENSE00001375534 | 6312159 | 6312364 |
| ENSE00002220184 | 6328136 | 6328506 |
| ENSE00003622407 | 6318993 | 6319108 |
| ENSE00003920478 | 6310682 | 6310848 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 96.04.
FANTOM5 (CAGE): breadth broad, TPM avg 2.2971 / max 81.8979, expressed in 496 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 123640 | 1.3313 | 423 |
| 123641 | 0.8730 | 285 |
| 123642 | 0.0544 | 26 |
| 123639 | 0.0384 | 18 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 96.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 94.69 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.40 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.70 | gold quality |
| transverse colon | UBERON:0001157 | 87.40 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 86.53 | silver quality |
| duodenum | UBERON:0002114 | 86.39 | gold quality |
| rectum | UBERON:0001052 | 85.85 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 85.68 | gold quality |
| small intestine | UBERON:0002108 | 84.78 | gold quality |
| jejunal mucosa | UBERON:0000399 | 84.02 | gold quality |
| buccal mucosa cell | CL:0002336 | 83.76 | silver quality |
| colonic epithelium | UBERON:0000397 | 83.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.86 | gold quality |
| minor salivary gland | UBERON:0001830 | 82.23 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.81 | gold quality |
| mouth mucosa | UBERON:0003729 | 81.77 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 81.11 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 80.54 | gold quality |
| omental fat pad | UBERON:0010414 | 80.28 | gold quality |
| peritoneum | UBERON:0002358 | 80.21 | gold quality |
| skin of leg | UBERON:0001511 | 80.15 | gold quality |
| placenta | UBERON:0001987 | 79.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 79.77 | gold quality |
| colonic mucosa | UBERON:0000317 | 79.65 | gold quality |
| adipose tissue | UBERON:0001013 | 79.47 | gold quality |
| vagina | UBERON:0000996 | 78.93 | gold quality |
| oral cavity | UBERON:0000167 | 78.92 | gold quality |
| intestine | UBERON:0000160 | 78.87 | gold quality |
| zone of skin | UBERON:0000014 | 78.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.19 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting PLEKHG6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
Literature-anchored findings (GeneRIF, showing 9)
- ezrin allows the local activation of RhoG at the apical pole of epithelial cells by recruiting upstream and downstream regulators of RhoG and that both PLEKHG6 and ezrin are required for efficient macropinocytosis (PMID:17881735)
- Plk1 can regulate MyoGEF activity and localization, contributing to the regulation of cytokinesis (PMID:18694934)
- MyoGEF cooperates with nonmuscle myosin IIA to regulate the polarity and invasion activity of breast cancer cells through activation of RhoA and RhoC. (PMID:19421144)
- GIPC1-MyoGEF complex formation plays an important role in regulating MDA-MB-231 breast cancer cell polarization and invasion. (PMID:20634288)
- Taken together, these results suggest that aurora B coordinates with Plk1 to regulate MyoGEF activation and localization, thus contributing to the regulation of cytokinesis. (PMID:24482237)
- Intramolecular interactions between MyoGEF domains act as an autoinhibitory mechanism for the regulation of MyoGEF functions. (PMID:25336641)
- Ezrin interacts with MYOGEF and recruits it to retracting blebs, where MYOGEF activates RhoA and promotes the reassembly of the cortical actomyosin network at the bleb membrane, thus contributing to the regulation of bleb retraction. (PMID:29321250)
- PLEKHG6 isoform is an example of a primate-specific genomic element supporting brain development. (PMID:30517861)
- Genetic Predisposition to Colon and Rectal Adenocarcinoma Is Mediated by a Super-enhancer Polymorphism Coactivating CD9 and PLEKHG6. (PMID:31988071)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plekhg6 | ENSDARG00000086056 |
| mus_musculus | Plekhg6 | ENSMUSG00000038167 |
| rattus_norvegicus | Plekhg6 | ENSRNOG00000019528 |
| drosophila_melanogaster | RhoGEF2 | FBGN0023172 |
| drosophila_melanogaster | cyst | FBGN0032796 |
| caenorhabditis_elegans | WBGENE00006468 | |
| caenorhabditis_elegans | prhg-1 | WBGENE00022391 |
Paralogs (8): ARHGEF1 (ENSG00000076928), ARHGEF18 (ENSG00000104880), ARHGEF2 (ENSG00000116584), ARHGEF11 (ENSG00000132694), ARHGEF3 (ENSG00000163947), NET1 (ENSG00000173848), ARHGEF12 (ENSG00000196914), ARHGEF28 (ENSG00000214944)
Protein
Protein identifiers
Pleckstrin homology domain-containing family G member 6 — Q3KR16 (reviewed: Q3KR16)
Alternative names: Myosin-interacting guanine nucleotide exchange factor
All UniProt accessions (3): Q3KR16, A0A2X0TW08, F5H731
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide exchange factor activating the small GTPase RHOA, which, in turn, induces myosin filament formation. Also activates RHOG. Does not activate RAC1, or to a much lower extent than RHOA and RHOG. Part of a functional unit, involving PLEKHG6, MYH10 and RHOA, at the cleavage furrow to advance furrow ingression during cytokinesis. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with EZR, required for normal macropinocytosis.
Subunit / interactions. Interacts with MYH10. Interacts with ELMO1 and EZR (in an open conformation). Interacts with CSPP1.
Subcellular location. Cell projection. Microvillus. Cytoplasm. Cytoskeleton. Spindle. Spindle pole. Cleavage furrow.
Tissue specificity. Highest expression in the placenta. Low levels in small intestine, lung, liver, kidney, thymus and heart.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q3KR16-1 | 1 | yes |
| Q3KR16-2 | 2 | |
| Q3KR16-3 | 3 |
RefSeq proteins (10): NP_001138328, NP_001138329, NP_001371527, NP_001371528, NP_001371529, NP_001371530, NP_001371531, NP_001371532, NP_001371533, NP_060643 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000219 | DH_dom | Domain |
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR035899 | DBL_dom_sf | Homologous_superfamily |
| IPR042918 | PLEKHG6 | Family |
Pfam: PF00621
UniProt features (18 total): compositionally biased region 4, region of interest 4, splice variant 3, domain 2, sequence conflict 2, chain 1, sequence variant 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3KR16-F1 | 68.36 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 351 | loss of exchange activity. |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-8980692 | RHOA GTPase cycle |
| R-HSA-9013149 | RAC1 GTPase cycle |
MSigDB gene sets: 93 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GATA3_01, TCF11_01, HNF4_DR1_Q3, ARGGGTTAA_UNKNOWN, GATA1_04, GATA1_02, GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GATA_Q6, GOCC_SPINDLE, GOCC_MICROVILLUS, GOCC_CELL_DIVISION_SITE, MARSON_BOUND_BY_FOXP3_UNSTIMULATED
GO Biological Process (1): regulation of small GTPase mediated signal transduction (GO:0051056)
GO Molecular Function (3): guanyl-nucleotide exchange factor activity (GO:0005085), GTPase activator activity (GO:0005096), protein binding (GO:0005515)
GO Cellular Component (10): spindle pole (GO:0000922), centrosome (GO:0005813), cytosol (GO:0005829), microvillus (GO:0005902), cell junction (GO:0030054), cleavage furrow (GO:0032154), cytoplasm (GO:0005737), spindle (GO:0005819), cytoskeleton (GO:0005856), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RHO GTPase cycle | 2 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| GTPase regulator activity | 2 |
| intracellular membraneless organelle | 2 |
| small GTPase-mediated signal transduction | 1 |
| regulation of intracellular signal transduction | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| binding | 1 |
| spindle | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| cytoplasm | 1 |
| actin filament bundle | 1 |
| actin-based cell projection | 1 |
| cell division site | 1 |
| plasma membrane region | 1 |
| intracellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
Protein interactions and networks
STRING
550 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PLEKHG6 | RHOG | P35238 | 718 |
| PLEKHG6 | RHOA | P06749 | 652 |
| PLEKHG6 | CSPP1 | Q1MSJ5 | 642 |
| PLEKHG6 | EZR | P15311 | 604 |
| PLEKHG6 | PLEK2 | Q9NYT0 | 481 |
| PLEKHG6 | PLEK | P08567 | 478 |
| PLEKHG6 | TRNP1 | Q6NT89 | 448 |
| PLEKHG6 | ARHGEF33 | A8MVX0 | 447 |
| PLEKHG6 | ARHGEF11 | O15085 | 432 |
| PLEKHG6 | TMEM14B | Q9NUH8 | 428 |
| PLEKHG6 | RABIF | P47224 | 425 |
| PLEKHG6 | ARHGEF19 | Q8IW93 | 418 |
| PLEKHG6 | ARHGEF15 | O94989 | 415 |
| PLEKHG6 | FGD3 | Q5JSP0 | 404 |
| PLEKHG6 | PLEKHG4B | Q96PX9 | 396 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP55 | PLEKHG6 | psi-mi:“MI:0915”(physical association) | 0.780 |
| PLEKHG6 | CEP55 | psi-mi:“MI:0915”(physical association) | 0.780 |
| PLEKHG6 | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| PLEKHG4 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHG6 | CEP55 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (55): PLEKHG6 (Two-hybrid), PCDHGA5 (Affinity Capture-MS), BPIFA2 (Affinity Capture-MS), CST1 (Affinity Capture-MS), C9orf41 (Affinity Capture-MS), CST5 (Affinity Capture-MS), PIGR (Affinity Capture-MS), IGJ (Affinity Capture-MS), ZG16B (Affinity Capture-MS), GSN (Affinity Capture-MS), ACTB (Affinity Capture-MS), AMY1C (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), LIMA1 (Affinity Capture-MS), TMOD2 (Affinity Capture-MS)
ESM2 similar proteins: A2ARS0, A5PKW4, A6QQ91, B7ZNG0, C9JTQ0, D3ZG83, F1MUS9, O14523, O14559, O75064, O75427, O95996, P0C5W1, P46062, P58660, Q02779, Q16584, Q2KI85, Q2M1P5, Q2TAL5, Q3KR16, Q3U0S6, Q3U1Y4, Q3UHC7, Q3UMT1, Q5BJT1, Q5DTT2, Q5U464, Q5U651, Q5VWQ8, Q66HA1, Q66K74, Q66L42, Q69YU3, Q6P730, Q80XI6, Q80YF9, Q86VW2, Q86YV0, Q8C052
Diamond homologs: O94827, Q3KR16, Q66T02, Q6RFZ7, Q8R0J1, Q92888, Q9Z1I6, O75962, Q1LUA6, A2CG49, A8DYP0, E2RP94, F1M0Z1, M0R4F8, O15068, O60229, P10911, P97924, Q0KL02, Q58EX7, Q63406, Q64096, Q6KAU7, Q6P720, Q80U35, Q86VW2, Q96PX9, Q9CWR0, Q9H7P9
SIGNOR signaling
4 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PLK1 | up-regulates | PLEKHG6 | phosphorylation |
| AURKB | up-regulates | PLEKHG6 | phosphorylation |
| PLEKHG6 | “up-regulates activity” | RHOA | “guanine nucleotide exchange factor” |
| PLEKHG6 | “up-regulates activity” | RAC1 | “guanine nucleotide exchange factor” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
196 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 167 |
| Likely benign | 15 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2676 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:6312361:GCTG:G | donor_gain | 1.0000 |
| 12:6312362:CTGGT:C | donor_loss | 1.0000 |
| 12:6312363:TGG:T | donor_loss | 1.0000 |
| 12:6312365:G:GG | donor_gain | 1.0000 |
| 12:6312365:GTGA:G | donor_loss | 1.0000 |
| 12:6312366:T:G | donor_loss | 1.0000 |
| 12:6315000:CCCA:C | acceptor_loss | 1.0000 |
| 12:6315002:CA:C | acceptor_loss | 1.0000 |
| 12:6315003:A:AG | acceptor_gain | 1.0000 |
| 12:6315003:AG:A | acceptor_gain | 1.0000 |
| 12:6315003:AGG:A | acceptor_loss | 1.0000 |
| 12:6315004:G:A | acceptor_loss | 1.0000 |
| 12:6315004:G:GG | acceptor_gain | 1.0000 |
| 12:6315004:GG:G | acceptor_gain | 1.0000 |
| 12:6315004:GGA:G | acceptor_gain | 1.0000 |
| 12:6315004:GGAA:G | acceptor_gain | 1.0000 |
| 12:6315529:T:A | acceptor_gain | 1.0000 |
| 12:6315552:A:AG | acceptor_gain | 1.0000 |
| 12:6315552:AG:A | acceptor_gain | 1.0000 |
| 12:6315553:G:GA | acceptor_gain | 1.0000 |
| 12:6315553:G:GC | acceptor_loss | 1.0000 |
| 12:6315553:GG:G | acceptor_gain | 1.0000 |
| 12:6315553:GGA:G | acceptor_gain | 1.0000 |
| 12:6315553:GGAGA:G | acceptor_gain | 1.0000 |
| 12:6315648:AT:A | donor_gain | 1.0000 |
| 12:6315649:TGTGA:T | donor_loss | 1.0000 |
| 12:6315650:G:GG | donor_gain | 1.0000 |
| 12:6315651:T:A | donor_loss | 1.0000 |
| 12:6315866:CA:C | acceptor_loss | 1.0000 |
| 12:6315867:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000169249 (12:6308942 G>A), RS1000404929 (12:6313221 G>A,T), RS1000652319 (12:6312196 G>C), RS1000739497 (12:6308386 G>A), RS1000754569 (12:6313365 C>G), RS1000783203 (12:6312787 G>A), RS1000894525 (12:6324056 G>A), RS1001058218 (12:6322402 C>G), RS1001104136 (12:6328436 C>A,T), RS1001407308 (12:6322712 C>A,T), RS1001662616 (12:6324170 C>A,T), RS1001674121 (12:6328906 A>G), RS1001733900 (12:6314321 G>T), RS1001918575 (12:6308777 C>A), RS1002141734 (12:6312669 C>G,T)
Disease associations
OMIM: gene MIM:611743 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_933 | Obesity-related traits | 9.000000e-06 |
| GCST002454_10 | Colorectal cancer | 6.000000e-10 |
| GCST003129_16 | Primary biliary cholangitis | 2.000000e-09 |
| GCST004866_8 | Alopecia areata | 8.000000e-06 |
| GCST007856_2 | Colorectal cancer or advanced adenoma | 1.000000e-08 |
| GCST011656_3 | Lung cancer | 9.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005116 | urinary metabolite measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 2 |
| Calcitriol | increases expression, affects cotreatment | 2 |
| Valproic Acid | affects cotreatment, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| ferrous chloride | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| licochalcone B | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Arsenic Trioxide | decreases response to substance | 1 |
| Arsenic | affects methylation | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance, affects cotreatment | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alopecia areata, colorectal adenoma, primary biliary cholangitis